SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Moolec Science S.A. (MLEC) has a negative trailing P/E of 0.0, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 1.2 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -2,799.72%, forward earnings yield 80.65%.
Criteria proven by this page:
- VALUE (50/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
- Forward P/E 1.2 — analysts expect a return to profitability with estimated EPS of $6.00 for FY2027.
- Trailing Earnings Yield -2,799.72% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 80.65% as earnings recover.
- Analyst consensus target $3.00 (-59.5% downside) — analysts see meaningful downside risk at the current price level.
Overall SharesGrow Score: 32/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
~
VALUE
50/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — MLEC
Valuation Multiples
P/E (TTM)0.0
Forward P/E1.2
PEG RatioN/A
Forward PEG0.00
P/B Ratio-0.06
P/S Ratio0.02
EV/EBITDA-3.7
Per Share Data
EPS (TTM)$-258.69
Forward EPS (Est.)$6.00
Book Value / Share$-192.34
Revenue / Share$774.28
FCF / Share$-69.87
Yields & Fair Value
Earnings Yield-2,799.72%
Forward Earnings Yield80.65%
Dividend Yield0.00%
Analyst Target$3.00 (-59.5%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2021 |
-122,956.7 |
0.00 |
12.66 |
0.00 |
- |
| 2022 |
-828.9 |
-0.06 |
2,338.83 |
0.00 |
- |
| 2023 |
-24.5 |
-0.02 |
125.51 |
1,401.43 |
- |
| 2024 |
-58.4 |
0.67 |
62.68 |
75.95 |
- |
| 2025 |
-0.4 |
0.00 |
-0.62 |
0.12 |
- |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2020 |
$0.00 |
$0.00 |
$-13.8K |
- |
| 2021 |
$-0.12 |
$0.00 |
$-4.53M |
- |
| 2022 |
$-1.50 |
$905.05K |
$-51.79M |
-5722.2% |
| 2023 |
$-0.19 |
$5.63M |
$-7.31M |
-130% |
| 2024 |
$-258.75 |
$333.61M |
$-111.46M |
-33.4% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$-36.00 |
$-36.00 – $-36.00 |
$8.63M |
$8.63M – $8.63M |
1 |
| 2027 |
$6.00 |
$6.00 – $6.00 |
$77.33M |
$77.33M – $77.33M |
1 |
| 2028 |
$30.00 |
$30.00 – $30.00 |
$130.77M |
$130.77M – $130.77M |
1 |
